In addition, Zgouras et al. showed treatment of the colon adenocarcinoma cell line Caco-2 with VPA caused significant reduction in vascular endothelial growth factor (VEGF) secretion, as well as negative regulation of VEGF mRNA and protein expression.48 This evidence concerns the gene VEGFA and colon adenocarcinoma.